alendronate plus d3 sandoz 70 mg/140 microgram alendronate (as sodium) 70 mg and colecalciferol 140 microgram (5600 iu) tablet b
dr reddys laboratories australia pty ltd - colecalciferol, quantity: 0.14 mg; alendronate sodium, quantity: 91.37 mg (equivalent: alendronic acid, qty 70 mg) - tablet, uncoated - excipient ingredients: gelatin; croscarmellose sodium; butylated hydroxytoluene; colloidal anhydrous silica; sucrose; magnesium stearate; microcrystalline cellulose; povidone; medium chain triglycerides - tradenames are indicated for the treatment of: ? osteoporosis* in select patients where vitamin d supplementation is recommended,* prior to treatment, osteoporosis must be confirmed by: - the finding of low bone mass of at least 2 standard deviations below the gender specific mean for young adults or by - the presence of osteoporotic fracture
alendronate plus d3 70 mg/140 ug apotex alendronate (as sodium) 70 mg and colecalciferol 140 microgram (5600 iu) tablet blister
dr reddys laboratories australia pty ltd - colecalciferol, quantity: 0.14 mg; alendronate sodium, quantity: 91.37 mg (equivalent: alendronic acid, qty 70 mg) - tablet, uncoated - excipient ingredients: magnesium stearate; povidone; sucrose; butylated hydroxytoluene; croscarmellose sodium; microcrystalline cellulose; gelatin; medium chain triglycerides; colloidal anhydrous silica - alendronate plus d3 70 mg/140 microgram apotex are indicated for the treatment of: osteoporosis in select patients where vitamin d supplementation is recommended, prior to treatment, osteoporosis must be confirmed by: - the finding of low bone mass of at least 2 standard deviations below the gender specific mean for young adults or by - the presence of osteoporotic fracture
fonatplus 70 mg/140 ug alendronate (as sodium) 70 mg and colecalciferol 140 microgram (5600 iu) tablet blister pack
dr reddys laboratories australia pty ltd - alendronate sodium, quantity: 91.37 mg (equivalent: alendronic acid, qty 70 mg); colecalciferol, quantity: 0.14 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; sucrose; gelatin; magnesium stearate; colloidal anhydrous silica; croscarmellose sodium; butylated hydroxytoluene; povidone; medium chain triglycerides - tradenames are indicated for the treatment of: ? osteoporosis* in select patients where vitamin d supplementation is recommended,* prior to treatment, osteoporosis must be confirmed by: - the finding of low bone mass of at least 2 standard deviations below the gender specific mean for young adults or by - the presence of osteoporotic fracture
colecalciferol
syri limited, t/a thame laboratories - colecalciferol - oral solution - 3000 iu/ml - colecalciferol
colecalciferol 3000 iu/ml oral solution
syri pharma limited t/a thame laboratories - colecalciferol - oral solution - 3000 international unit(s)/millilitre - colecalciferol
colecalciferol thame 10,000iu/ml oral solution
syri pharma limited floor 0 1 wml, 1 windmill lane dublin 2, d02 f206, ireland - colecalciferol - oral solution - colecalciferol 1000 iu/ml - vitamins
colecalciferol eql pharma 2000 iu tablet
eql pharma ab - colecalciferol - tablet - 2000 international unit(s) - colecalciferol
colecalciferol eql pharma 800 iu tablet
eql pharma ab - colecalciferol - tablet - 800 international unit(s) - colecalciferol
colecalciferol 800 iu capsules, soft
strides pharma (cyprus) limited - colecalciferol - capsule, soft - colecalciferol
colecalciferol 30000 iu film-coated tablets
consilient health limited - colecalciferol - film-coated tablet - 30000 international unit(s) - vitamin d and analogues; colecalciferol